Norethindrone

Norethindrone is a lipid of Sterol Lipids (ST) class. Norethindrone is associated with abnormalities such as Endometriosis, site unspecified, Wiskott-Aldrich Syndrome and Estrogenic effect. The involved functions are known as Hemorrhage, Phosphorylation, Apoptosis, DNA Repair and Cell Cycle. Norethindrone often locates in Blood, Back, Body tissue, Nucleolar and Human tissue. The associated genes with Norethindrone are MMP gene, NR3C1 gene and Genes, Reporter. The related lipids are Steroids, 4,17 beta-dihydroxy-4-androstene-3-one, 4-estren-3,17-diol and Estranes.

Cross Reference

Introduction

To understand associated biological information of Norethindrone, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Norethindrone?

Norethindrone is suspected in Endometriosis, site unspecified, Estrogenic effect and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Norethindrone

MeSH term MeSH ID Detail
Body Weight D001835 333 associated lipids
Arteriosclerosis D001161 86 associated lipids
Pancreatic Neoplasms D010190 77 associated lipids
Total 3

PubChem Associated disorders and diseases

What pathways are associated with Norethindrone

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Norethindrone?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Norethindrone?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Norethindrone?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Norethindrone?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Norethindrone?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Norethindrone

Download all related citations
Per page 10 20 50 100 | Total 3869
Authors Title Published Journal PubMed Link
Notelovitz M et al. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial. 1992 Am. J. Obstet. Gynecol. pmid:1442974
Beischer NA et al. Norethisterone and gestational diabetes. 1992 Aust N Z J Obstet Gynaecol pmid:1445134
MEARS E and GRANT EC "Anovlar" as an oral contraceptive. 1962 Br Med J pmid:14471933
RICE-WRAY E et al. Long-term administration of norethindrone in fertility control. 1962 JAMA pmid:14491906
Cano A et al. The lipid and clinical effects of sequential transdermal estradiol and estradiol/norethisterone acetate in 674 women. 2003 Arch. Gynecol. Obstet. pmid:14504877
pmid:14505262
Loke DF et al. Lipid and biochemical changes after low-dose oral contraception. 1992 Contraception pmid:1451519
Cameron I Management of menorrhagia. 1992 Practitioner pmid:1454734
Saure A et al. The effect of synthetic gestagens on progesterone formation in vitro in human placenta of early pregnancy. 1977 J. Reprod. Fertil. pmid:145492
Comparative study of the effects of two once-a-month injectable contraceptives (Cyclofem and Mesigyna) and one oral contraceptive (Ortho-Novum 1/35) on coagulation and fibrinolysis. 2003 Contraception pmid:14561536
de Visser SJ et al. Pharmacokinetic differences between Caucasian and Japanese subjects after single and multiple doses of a potential combined oral contraceptive (Org 30659 and EE). 2003 Contraception pmid:14561540
Fang H et al. Study of 202 natural, synthetic, and environmental chemicals for binding to the androgen receptor. 2003 Chem. Res. Toxicol. pmid:14565775
Jondet M and Dehennin L Impact of different progestins on endometrial vascularisation of postmenopausal women. A retrospective image analysis-morphometric study. 2003 Maturitas pmid:14585519
Pata O et al. The effects of hormone replacement therapy type on pulmonary functions in postmenopausal women. 2003 Maturitas pmid:14585524
pmid:14588124
Acharya U et al. Prospective study of short and ultrashort regimens of gonadotropin-releasing hormone agonist in an in vitro fertilization program. 1992 Fertil. Steril. pmid:1459268
McLeod LD et al. Evaluating minimal clinically important differences for the acne-specific quality of life questionnaire. 2003 Pharmacoeconomics pmid:14596626
pmid:14614424
Kaleli B et al. Effects of low-dose 17-beta-estradiol plus norethisterone acetate and tibolone on fasting plasma homocysteine levels in postmenopausal women. 2003 Acta Obstet Gynecol Scand pmid:14616255
pmid:14623061
Yilmazer M et al. Hormone replacement therapy, C-reactive protein, and fibrinogen in healthy postmenopausal women. 2003 Maturitas pmid:14625121
Cengiz B et al. Effect of hormone replacement therapy on serum levels of tumor markers in healthy postmenopausal women. 2003 Maturitas pmid:14625127
Roberts LM et al. Extraperitoneal endometriosis with catamenial pneumothoraces: a review of the literature. 2003 Oct-Dec JSLS pmid:14626406
Beksinska ME et al. Detection of raised FSH levels among older women using depomedroxyprogesterone acetate and norethisterone enanthate. 2003 Contraception pmid:14636937
Freeman WS When patients 'can't' take the pill. 1978 Am Fam Physician pmid:146420
Reddy LV et al. Glial cells maintain synaptic structure and function and promote development of the neuromuscular junction in vivo. 2003 Neuron pmid:14642280
Keller PJ et al. A transdermal regimen for continuous combined hormone replacement therapy in the menopause. 1992 Maturitas pmid:1465033
Hall SD et al. The interaction between St John's wort and an oral contraceptive. 2003 Clin. Pharmacol. Ther. pmid:14663455
Barr Laboratories recalls Nortrel contraceptive. 2003 Sep-Oct FDA Consum pmid:14666892
Stanczyk FZ All progestins are not created equal. 2003 Steroids pmid:14667980
pmid:14667983
Nagaoka S et al. The des-gamma-carboxy prothrombin index is a new prognostic indicator for hepatocellular carcinoma. 2003 Cancer pmid:14669288
Schindler AE et al. Classification and pharmacology of progestins. 2003 Maturitas pmid:14670641
Franke HR and Vermes I Differential effects of progestogens on breast cancer cell lines. 2003 Maturitas pmid:14670646
Tonetti DA Prevention of breast cancer by recapitulation of pregnancy hormone levels. 2004 Breast Cancer Res. pmid:14680493
Kidwai N et al. Expression of androgen receptor and prostate-specific antigen in male breast carcinoma. 2004 Breast Cancer Res. pmid:14680496
Rajkumar L et al. Prevention of mammary carcinogenesis by short-term estrogen and progestin treatments. 2004 Breast Cancer Res. pmid:14680498
Walker AE et al. PRIME--PRocess modelling in ImpleMEntation research: selecting a theoretical basis for interventions to change clinical practice. 2003 BMC Health Serv Res pmid:14683530
Scott AR et al. Effect of hormone replacement therapy on cardiovascular risk factors in postmenopausal women with diabetes. 2004 Diabetes Obes Metab pmid:14686958
pmid:14707779
Csizmadi I et al. The effects of transdermal and oral oestrogen replacement therapy on colorectal cancer risk in postmenopausal women. 2004 Br. J. Cancer pmid:14710210
Cagnacci A et al. Comparison of the effect of oral and transdermal hormone therapy on fasting and postmethionine homocysteine levels. 2004 Fertil. Steril. pmid:14711550
Archer DF et al. Effects of levonorgestrel, medroxyprogesterone acetate, norethindrone, and 17beta-estradiol on vascular endothelial growth factor isomers 121 and 165 in Ishikawa cells. 2004 Fertil. Steril. pmid:14711561
Crisafulli A et al. Effects of the phytoestrogen genistein on the circulating soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin system in early postmenopausal women. 2004 J. Clin. Endocrinol. Metab. pmid:14715848
pmid:14717620
Czarnecka D et al. The effect of hormone replacement therapy on endothelial function in postmenopausal women with hypertension. 2004 Med. Sci. Monit. pmid:14737044
Canto de Cetina TE et al. Menstrual pattern and lipid profiles during use of medroxyprogesterone acetate and estradiol cypionate and NET-EN (200 mg) as contraceptive injections. 2004 Contraception pmid:14759615
Webb A et al. Effect of hormonal emergency contraception on bleeding patterns. 2004 Contraception pmid:14759618
Schmitt K et al. [Reduction of body height in tall girls by estrogen treatment]. 1992 Nov-Dec Klin Padiatr pmid:1479793
Djerassi C Steroid research at Syntex: "the pill" and cortisone. 1992 Steroids pmid:1481227